Search Result "CD30"
Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 7 Year: 2017 Page: 886-895
Author(s): Alberto Fabbri,Emanuele Cencini,Alessandro Gozzetti,Luana Schiattone,Monica Bocchia
Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo
Journal: Current Drug Targets
Volume: 10 Issue: 2 Year: 2009 Page: 110-117
Author(s): B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein, H. Durkop
Monoclonal Antibody Therapy in Haematological Malignancies
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 148-159
Author(s): Martine E.D. Chamuleau, Arjan A. van de Loosdrecht, Peter C. Huijgens
Immune Restoration Disease: A Consequence of Dysregulated Immune Responses After HAART
Journal: Current HIV Research
Volume: 2 Issue: 3 Year: 2004 Page: 235-242
Author(s): Shelley F. Stone, Patricia Price, Martyn A. French
Immunotoxins in the Treatment of Hematologic Malignancies
Journal: Current Drug Targets
Volume: 7 Issue: 1 Year: 2006 Page: 1301-1311
Author(s): Robert J. Kreitman, Ira Pastan
New Insights into Acute and Chronic Lung Rejection
Journal: Current Respiratory Medicine Reviews
Volume: 4 Issue: 1 Year: 2008 Page: 40-51
Author(s): Isabel Neuringer, Ayorinde Medaiyese, Patrick McNeillie, Steven Budd, Robert Aris
Tumor Necrosis Factor Inhibitors from Poxviruses with An Emphasis on Tanapoxvirus-2L Protein
Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 5 Issue: 2 Year: 2011 Page: 97-103
Author(s): David Jeng, Masmudur M. Rahman, Grant McFadden, Karim Essani
Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 2693-2699
Author(s): Mehmet Kemal Tur, Inga Neef, Gernot Jager, Andreas Teubner, Michael Stocker, Georg Melmer, Stefan Barth
Natural Products as Exquisitely Potent Cytotoxic Payloads for Antibody- Drug Conjugates
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 24 Year: 2014 Page: 2822-2834
Author(s): Samantha M. Gromek,Marcy J. Balunas
Recombinant Interleukin-12 for Immunotherapy: A Double-Sided Sword
Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5 Issue: 3 Year: 2005 Page: 269-276
Author(s): A. Hombach, C. Heuser, A. Stallmach, H. Abken